Lv4
790 积分 2023-07-28 加入
Discovery of novel CDK2 inhibitors using multistage virtual screening and in vitro melanoma cell lines
11天前
已完结
Combined inhibition of EZH2 and the autotaxin-LPA-LPA2 axis exerts synergistic antitumor effects on colon cancer cells
23天前
已完结
Autotaxin facilitates selective LPA receptor signaling
24天前
已完结
Trends in the drug target landscape for autoimmune diseases
28天前
已完结
Glucose transporters: expression, regulation and cancer
1个月前
已完结
Lysosome Targeting Chimaeras for Glut1-Facilitated Targeted Protein Degradation
1个月前
已完结
Low Molecular Weight Cyclin E Confers a Vulnerability to PKMYT1 Inhibition in Triple-Negative Breast Cancer
1个月前
已完结
Discovery and preclinical evaluations of TQB3616, a novel CDK4-biased inhibitor
1个月前
已完结
Discovery of potent and selective CDK2 inhibitors with high safety and favorable bioavailability for the treatment of cancer
1个月前
已完结
Tumor Suppressors Condition Differential Responses to the Selective CDK2 Inhibitor BLU-222
1个月前
已完结
皖公网安备34019202002308
